National Health Investors Reports Q3 2026 Results, Cuts FFO Guidance
National Health Investors reported normalized FFO of $1.12 per share, in line with FactSet estimates, and quarterly revenue of $113.5 million. It set 2026 normalized FFO guidance at $4.68–$4.70 per share, below FactSet consensus of $4.75.
National Health Investors, Inc. reported its financial results for the third quarter of 2026, posting normalized FFO of $1.12 per share, which aligned with FactSet analyst estimates. The company reported quarterly revenue of $113.5 million. Alongside the earnings release, the company updated its full-year 2026 normalized FFO per share guidance to a range of $4.68 to $4.70, which compares to the FactSet consensus estimate of $4.75.
CEO Eric Mendelsohn noted that the company is focused on its long-term growth strategy, particularly within its SHOP and private-pay senior housing segments, and has strengthened its management team to address portfolio underperformance.